A study of the effect of recombinant osteopontin administration on protection against cerebral infarction in rats showed that OPN inhibited the activation of the NLRP3 inflammasome33, suggesting that it may also be involved in inhibiting systemic inflammation during ketosis. This evidence concerns the gene SPP1 and cerebral infarction.